for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

Solid Biosciences say FDA lifts halt on gene therapy trial

Oct 1 (Reuters) - Solid Biosciences Inc said on Thursday the U.S. Food and Drug Administration (FDA) has lifted the clinical halt placed on a trial of its experimental gene therapy for a muscle-wasting disorder.

The trial was halted in November for a second time in less than two years after a seven-year-old-boy experienced serious complications.

Shares of the company were up nearly 60% in premarket trading after the news. (Reporting By Mrinalika Roy in Bengaluru; Editing by Aditya Soni)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up